UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011428
Receipt number R000013379
Scientific Title Effect of antipsychotic risperidone on presynaptic dopaminergic function
Date of disclosure of the study information 2013/08/08
Last modified on 2014/08/08 13:40:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of antipsychotic risperidone on presynaptic dopaminergic function

Acronym

Effect of antipsychotic risperidone on presynaptic dopaminergic function

Scientific Title

Effect of antipsychotic risperidone on presynaptic dopaminergic function

Scientific Title:Acronym

Effect of antipsychotic risperidone on presynaptic dopaminergic function

Region

Japan


Condition

Condition

Healthy male volunteer

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We aim to measure change in dopamine transporter availability by an antipsychotic, risperidone, by using positron emission tomography (PET) with [18F]FE-PE2I in healthy subjects. PET scans will be performed twice after single dose of risperidone. We will also perform magnetic resonance imaging (MRI) and psychological tests on the same day the PET scans are performed.

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in dopamine transporter availability by single dose of risperidone and its relevance to performance in psychological test as well as brain functions measured by MRI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

risperidone 2.0 mg p.o

Interventions/Control_2

placebo p.o

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male

Key inclusion criteria

Healthy volunteers who do not have any psychiatric disorders or serious medical illnesses and who are able to understand an explanatory document and give consent are included in this study

Key exclusion criteria

-Psychiatric disorders including drug dependence
-Serious medical illness

Target sample size

13


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuyuki Kimura

Organization

National Institute of Radiological Sciences

Division name

Molecular Imaging Center

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba

TEL

043-206-3251

Email

y-kimura@nirs.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Susumu Tamoyama

Organization

National Institute of Radiological Sciences

Division name

A study ethic plan support room

Zip code


Address

4-9-1 Anagawa, Inage-ku, Chiba

TEL

043-206-3193

Homepage URL


Email

helsinki@nirs.go.jp


Sponsor or person

Institute

National Institute of Radiological Sciences

Institute

Department

Personal name



Funding Source

Organization

National Institute of Radiological Sciences

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

独立行政法人 放射線医学総合研究所


Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2013 Year 01 Month 21 Day

Date of IRB


Anticipated trial start date

2013 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 08 Month 08 Day

Last modified on

2014 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013379


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name